ProPhase Labs, Inc. Gains 29.84%

ProPhase Labs, Inc. (PRPH:NASDAQ) soared at $0.57, a gain of 29.8%. On Wed, Feb 19, 2025, PRPH:NASDAQ touched a New 2-Week High of $0.57. The stock got featured on our News Catalysts scanner on Sat, Feb 15, 2025 at 08:48 PM in the 'BIOTECH' category. From Wed, Feb 05, 2025, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Tue, Feb 18, 2025 at $0.68 with a volume of 178M+.
About ProPhase Labs, Inc. (PRPH:NASDAQ)
ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is also engaged in the research & development of potential over-the-counter drug, natural health products, supplements, personal care & cosmeceutical products.
Top 10 Gainers:
- JetAI Inc Com (JTAI:NASDAQ), 150%
- F45 Training Holdings Inc. (FXLV:NYSE), 92.08%
- Editas Medicine, Inc. (EDIT:NASDAQ), 83.91%
- OSR Holdings Inc. (OSRH:NASDAQ), 75.56%
- Sintx Technologies, Inc. (SINT:NASDAQ), 70.92%
- Lytus Technologies Holdings PTV. Ltd. (LYT:NASDAQ), 61.73%
- Aureus Greenway Holdings Inc. (AGH:NASDAQ), 42.44%
- HUHUTECH International Group Inc. (HUHU:NASDAQ), 32%
- MicroVision, Inc. (MVIS:NASDAQ), 31.58%
- ProPhase Labs, Inc. (PRPH:NASDAQ), 29.84%